SEC Form 4 · accession 0001127602-16-037498
BIOCRYST PHARMACEUTICALS INC · BCRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jon P Stonehouse
Officer — President & CEO · Director
Period of report
Jan 20, 2016
Accepted (ET)
Jan 21, 2016 · 1:12 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000882796
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 20, 2016 | M | 24,096 | $4.15 | A | 676,326 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Emp. Stock Option (Right to Buy) | $4.15 | Jan 20, 2016 | M | 24,096 | D | Mar 1, 2012 | Mar 1, 2021 | Common Stock | 24,096 | 134,279 | D |